MedPath

Testing Latest Version of NidekRS3000Adv

Completed
Conditions
Glaucoma
Registration Number
NCT03318705
Lead Sponsor
Doheny Image Reading Center
Brief Summary

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Healthy participants
  • 18 years old or older
Exclusion Criteria
  • Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging
  • subjects who are unable to maintain retinal fixation on a specified target
  • subjects unable to achieve sufficient pupil dilation and alignment stability for imaging to take place
  • subjects with media opacity which preclude high quality imaging will be excluded.
  • vulnerable subjects
  • subjects under 18
  • pregnant subjects
  • economically and educationally disadvantaged subjects
  • decision impaired subjects
  • homeless subjects

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ocular vascularization1 year

Nidek RS3000Adv device to be used to take images which will allow measurement of vascularization in participants

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Doheny Eye Centers UCLA

🇺🇸

Pasadena, California, United States

© Copyright 2025. All Rights Reserved by MedPath